BACKGROUND/OBJECTIVES: The objective of this study was to examine the association between body mass index (BMI) and the annual estimated glomerular filtration rate (eGFR) decline in a rural lean Chinese cohort. SUBJECTS/METHODS: A total of 2696 subjects with an eGFR ⩾ 60 ml/min per 1.73 m 2 were followed up for 7 years. Our primary outcome was annual eGFR decline, calculated as (eGFR at baseline − eGFR at revisit)/years of follow-up. RESULTS: During the 7-year follow-up, the mean (s.d.) of annual eGFR decline was 1.7 (1.9) ml/min per 1.73 m 2 per year. Compared with subjects with normal weight (BMI 19-22.9 kg/m 2 ), overweight subjects (BMI 23-26.9 kg/m 2 ) had a more rapid annual eGFR decline (β, 0.33; 95% confidence interval (0.18-0.47) ml/min per 1.73 m 2 per year), whereas no significant difference was found when comparing the underweight (o19 kg/m 2 ) and the obese (⩾27 kg/m 2 ) groups with the normal-weight group. Moreover, in the 19-to 26.9-kg/m 2 range, BMI was positively linearly associated with annual eGFR decline (β2, 0.09 (0.05 to 0.12) ml/min per 1.73 m 2 per year, P o0.001), whereas in the o19 (β1, − 0.21(−0.45-0.02), P = 0.073; β2 versus β1: P = 0.009) and ⩾ 27 kg/m 2 (β3, − 0.24 (−0.48-0.00), P = 0.053; β3 versus β2: P = 0.010) range a negative but statistically insignificant trend of association was detected. CONCLUSIONS: Our results suggested a nonlinear S-shaped association between BMI and annual eGFR decline among Chinese adults with normal renal function.
INTRODUCTION
Chronic kidney disease (CKD) is now recognized as a worldwide public health problem. 1 A recent national cross-sectional survey 2 showed that the overall prevalence of CKD in adult Chinese was 10.8% (10.2-11.3), estimating 119.5 million adults aged 18 years or older to have CKD in China. Even mild impairment of renal function is shown to be associated with an increased risk for CVD and mortality. 3, 4 A better understanding of the modifiable risk factors of renal function impairment in apparently healthy population, leading to early detection and prevention, might alleviate the future burden of CKD and its associated complications.
Although obesity has been established as a risk factor for CVD, its role in developing CKD remains controversial. Physicians' Health Study 5 showed that body mass index (BMI) was a strong predictor for developing CKD in 11 104 initially healthy men after a 14-year follow-up, and the Coronary Artery Risk Development in Young Adults study 6 also found that increasing BMI was associated significantly with a rapid estimated glomerular filtration rate (eGFR) decline (43% decline per year) in 2839 black and white young adults with baseline eGFR 490 ml/min per 1.73 m 2 over 10 years of follow-up. However, Oh H et al. 7 failed to establish the association between BMI and renal function decline (RFD) in a Korean population after the 6-year follow-up. Meanwhile, Luk et al. 8 detected an inverse association between BMI and incident CKD in 5829 patients with type 2 diabetes from Hong Kong. In a meta-analysis conducted by Wang et al. 9 on BMI and CKD, compared with normal-weight individuals, the pooled relative risks (95% confidence interval (CI)) were 1.30 (0.52-3.24), 1.26 (1.10-1.45) and 1.34 (0.86-2.09) for underweight (BMIo18.5 kg/m 2 ), overweight (25-29.9 kg/m 2 ) and obese (⩾30 kg/m 2 ) individuals, respectively. Furthermore, it is unclear whether the relationship between BMI and CKD or RFD observed among predominantly overweight individuals in these developed areas should also apply to persons at the lower end of the BMI distribution. Hence, data from lean populations in developing countries such as China can be informative.
Therefore, we aimed to examine the association between BMI and decline of renal function, defined as annual estimated glomerular filtration (eGFR) decline, in a rural lean Chinese population with normal renal function.
MATERIALS AND METHODS

Study population
Study participants were from an epidemiological study of metabolic syndrome conducted during 2003-2005 with enrollment of 18 630 subjects in rural communities (Dongzhi and Wangjiang) in Anqing, Anhui province of China. A detailed protocol of the study was described previously. 10 In 2011, 6301 of the study subjects from the Dongzhi community who received baseline screening examination were invited for a follow-up visit, and 2901 (46%) of them responded. The nonresponders did not differ substantially from the responders with respect to baseline characteristics ( Supplementary Table 1 ). Of the 2901 subjects revisited, 66 subjects had one or more missing baseline values in age, smoking status, drinking status, physical activity level or fasting glucose, and 139 subjects had a baseline eGFR value of o60 ml/min per 1.73 m 2 . We excluded the above-mentioned subjects in our analyses, resulting in a final sample size of 2696 (1423 men and 1273 women).
This study was approved by the Institutional Review Boards from the Nanfang Hospital in Guangzhou and the Institute of Biomedicine in the 1 Anhui Medical University. Written informed consent was obtained from each study participant.
Data collection
Baseline data including questionnaires on sociodemographic status, occupation, diet, lifestyle, health behavior, medical history, blood pressure and anthropometric measurements, as well as blood tests, were collected by trained research staff according to protocols described previously. 10 Height was measured without shoes to the nearest 0.1 cm on a portable stadiometer. Weight was measured in light indoor clothing without shoes to the nearest 0.1 kg. BMI was calculated as weight/height squared (kg/m 2 ). Physical activity level was self-reported as mild, moderate and heavy.
Venous blood was drawn from the forearm of each participant in the fasting status. Serum and plasma were separated from blood cells in the field within 30 min and kept frozen at − 20°C. Serum creatinine concentrations were determined using an enzymatic method (sarcosine oxidase-PAP). Fasting blood glucose, total cholesterol (TC), triglyceride (TG) and high-density lipoprotein-cholesterol (HDL-C) were measured on the Hitachi 7020 Automatic Analyzer (Hitachi, Tokyo, Japan). Serum creatinine concentrations at the follow-up year were measured in the same central laboratory as at baseline.
GFR was estimated using the following equation where Scr is serum creatinine (mg/dl), κ is 0.7 for women and 0.9 for men, α is − 0.329 for women and − 0.411 for men, min indicates the minimum of Scr/κ or 1 and max indicates the maximum of Scr/κ or 1.
Outcomes
Our primary outcome was annual eGFR decline calculated as (eGFR at baseline − eGFR at revisit)/years of follow-up. The secondary outcomes included rapid eGFR loss, defined as an annual decline in eGFR of 43 ml/min per 1.73 m 2 per year, [12] [13] [14] and RFD, defined as a drop in GFR category (⩾90 (G1), 60-89 (G2), 45-59 (G3a), 30-44 (G3b), 15-29 (G4), o15 (G5) ml/min per 1.73 m 2 ) accompanied by a 25% or greater drop in eGFR from baseline or a sustained decline in eGFR of 45 ml/min per 1.73 m 2 per year according to the Kidney Disease: Improving Global Outcome (KDIGO) 2012. 15 Statistical Analysis BMI was categorized into underweight ( o19 kg/m 2 ), normal weight (⩾19 and o23 kg/m 2 ), overweight (⩾23 and o27 kg/m 2 ) and obese (⩾27 kg/m 2 ), on the basis of the assumption that the percentage of body fat in the Hong Kong population at the cutoff points for overweight and obesity was the same as the percentage of body fat in white people with a BMI of 25 and 30 kg/m 2 , respectively. 16 Hypertension was defined as systolic blood pressure ⩾ 140 mm Hg or diastolic blood pressure ⩾ 90 mm Hg or selfreported diagnosis of hypertension. Diabetes was defined as fasting glucose ⩾ 7.0 mmol/l or self-reported diagnosis of diabetes. Hypercholesterolemia was defined as TC ⩾ 5.2 mmol/l. High TG was defined as TG ⩾ 1.7 mmol/l and low HDL-C was defined as HDL-C o0.9 mmol/l. Current smoking was defined as having smoked ⩾ 10 packs in the past year. Current drinking was defined as drinking alcohol at least once per week in the past year.
Baseline characteristics are presented as the mean (continuous variables) or percentage (categorical variables). Differences between men and women in baseline characteristics were tested using the Student's t-test or the Χ 2 test, accordingly. The effects of BMI (as a continuous variable and a categorical variable, respectively) on the annual eGFR decline and developing rapid eGFR loss and RFD were estimated using linear or logistic regression models accordingly, with adjustment for baseline covariates including age, sex, eGFR, hypertension, diabetes, dyslipidemia (hypercholesterolemia, high TG and low HDL-C), cigarette smoking, alcohol consumption and physical activity level. We also tested for effect modification of the above covariates on annual eGFR decline using the likelihood ratio test. In addition, we explored the possible nonlinear relationship between BMI and annual eGFR decline, rapid eGFR loss and RFD using restricted cubic splines with knot locations generated automatically in generalized additive models 17 in the R package mgcv. Meanwhile, we conducted linear regression analysis to examine the association between BMI and annual eGFR decline within each strata of BMI (o19, 19-26.9 and ⩾ 27 kg/m 2 ) and Wald Χ 2 test was used to test the effect between strata. Two-tailed Po0.05 was considered to be statistically significant in all analyses. R software, version 2.15.1 (http://www.R-project. org/) was used to perform all statistical analyses.
RESULTS
The baseline characteristics of the study subjects stratified by gender are summarized in Table 1 . The average age of the study subjects at baseline was 50.4 years, with a mean (s.d.) BMI of 21.3 (2.4) kg/m 2 in men and 22. (2.7) kg/m 2 in women. The prevalence of overweight (BMI 23-26.9 kg/m 2 ) and obesity (BMI ⩾ 27 kg/m 2 ) was 23.8% and 3.2%, respectively, and it was much higher in women (29.6% and 4.4%, respectively) than in men (18.6% and 2.1%, respectively). Men had significantly higher age, waist circumference, diastolic blood pressure, HDL-C and physical activity level, but lower BMI, TC, TG and baseline eGFR compared with women. Cigarette smoking and alcohol consumption were common in men but very rare in women ( Of the 2696 study subjects, the mean (s.d.) and the median of annual eGFR decline during the 7-year follow-up (interquartile range: 7.0-7.1) was 1.7 (1.9) and 1.8 ml/min per 1.73 m 2 per year, respectively; 19.8% had rapid eGFR loss and 9.0% had RFD. When analyzed as a continuous exposure (per 1 kg/m 2 increment), BMI was associated with a more rapid annual eGFR decline (β, 0.05; 95% CI: 0.03-0.08 ml/min per 1.73 m 2 per year) and increased odds ratios (ORs) for rapid eGFR loss (OR: 1.05; 95% CI: 1.01-1.09) and RFD (OR: 1.05; 95% CI: 0.99-1.09), respectively. However, compared with normal weight (BMI 19-22.9 kg/m 2 ), overweight (BMI 23-26.9 kg/m 2 ) was significantly associated with a more rapid annual eGFR decline (β, 0.33; 95% CI: 0.18-0.47 ml/min per 1.73 m 2 per year), as well as increased ORs of rapid eGFR loss (OR: 1.52; 95% CI: 1.20-1.93) and RFD (OR: 1.39; 95% CI: 1.01-1.91), whereas no significant difference was found when comparing the underweight (o19 kg/m 2 ) and the obese (⩾27 kg/m 2 ) groups with the normal-weight group (Table 2, Figure 1 ). Similar trends between BMI category and annual eGFR decline were observed among age o50 or ⩾ 50 years, men and women, the presence or absence of hypertension, the presence or absence of diabetes, TC o5.2 or ⩾ 5.2 mmol/l, TG o1.7 or ⩾ 1.7 mmol/l, HDL ⩾ 0.9 or o0.9 mmol/l, nonsmoking or smoking, nondrinking or drinking, physical activity levels (mild, moderate and heavy) and baseline eGFR ⩾ 110 or 60-110 ml/min per 1.73 m 2 (P for interaction 40.05 for all).
In models using restricted cubic spline, a nonlinear S-shaped association between BMI and annual eGFR decline, as well as rapid eGFR loss and RFD, was observed ( Figure 2) .
Meanwhile, in the 19-to 26.9-kg/m 2 range, BMI was positively linearly associated with annual eGFR decline (β2, 0.09; 95% CI: 0.05-0.12 ml/min per 1.73 m 2 per year), whereas in the o19 (β1, -0.21; 95% CI: − 0.45-0.02; β2 versus β1: P = 0.009) or ⩾ 27 (β3, − 0.24; 95% CI: − 0.48-0.00; β3 versus β2: P = 0.010) range a negative but statistically insignificant trend of association was detected.
DISCUSSION
Only two prospective studies 8, 18 have examined the relationship of BMI with incident CKD or RFD in the Chinese population. (OR for per 1 kg/m 2 BMI increment, 1.05; 0.81-1.35). Our study was the first to examine the association between BMI and decline of renal function in a lean Chinese population with normal kidney function, and suggested a nonlinear S-shaped relationship of BMI with renal dysfunction outcomes including annual eGFR decline, rapid eGFR loss and RFD. Our findings may partly explain the negative findings observed in the previous studies in the Chinese population 8, 18 with enrollment of relatively obese subjects with average BMI of 25.1 and 25.3 kg/m 2 . Of course, more studies are needed to verify whether our findings can be generalized to other populations. The potential mechanisms for obesity-related CKD involve inflammation, cellular lipid overload, hemodynamic effects and perhaps other unknown mechanisms. 19 In our study, overweight (BMI of 23-26.9 kg/m 2 ) was significantly associated with renal dysfunction, even independently of hypertension and diabetes, the two conditions often linked to obesity. Consistently, in the Physicians' Health Study, 5 which enrolled 11 104 initially healthy men for an average 14-year of follow-up, compared to BMI o22.7 kg/m 2 , higher BMI groups were associated with an increased risk for CKD. This association was nonlinear and independent of the baseline status of diabetes and hypertension. As compared with BMIo21.7 kg/m 2 , BMI of 22.7-23.7, 23.8-25.0, 25.1-26.6 and 426.6 kg/m 2 had adjusted ORs of 1.13, 1.15, 1.32 and 1.26, respectively. 5 In our study, the obese group (BMI ⩾ 27 kg/m 2 ) had a slightly lower annual eGFR decline than the overweight group, although the difference is not statistically significant. Obese individuals usually have an increased plasma volume and cardiac output, resulting in so-called ultrafiltration that served as a compensatory mechanism to maintain sodium balance in the face of increased tubular reabsorption. 20 Henegar et al. 21 found that obese dogs have a 38 ± 6% greater GFR and a 61 ± 7% higher renal plasma flow compared with lean dogs. Consistently, Elsayed et al. 22 demonstrated that increased BMI was protective for the composite outcome of incident CKD and mortality in a population of 13 324 participants with average BMI of 27.2 kg/m 2 after 9.3 years of follow-up from Atherosclerosis Risk in Communities Study and Cardiovascular Health Study. More recently, Kao et al. 23 found an inverse association between BMI and CKD among diabetic older patients, with ORs of 3.71, 2.32, 2.12 and 1.31 in underweight, normal, overweight and obese subjects, respectively, compared with nondiabetic subjects with normal weight. Similarly, the Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension trial 24 showed that cardiovascular deaths or nonfatal myocardial infarctions or strokes occurred more frequently in normal-weight patients than in obese hypertensive patients. Whether this 'paradox' represents a change in the causal association between obesity, the classically understood risk factor, and clinical outcomes or a failure to adequately account for more confounding factors needs more research.
We observed a flat or slightly negative relationship between BMI and decline of renal function at the low spectrum of BMI (o19 kg/m 2 ). The relationship between BMI and renal function change may be compounded by the fact that lean subjects tend to have a lower production of creatinine and higher eGFR. 25 Future studies are needed to confirm our results.
Our study has several limitations. First, our study population was from a rural cohort with low average BMI levels, and it was not the representative of the general Chinese population; its generalizability to other populations or ethnicities or subjects with CKD should take caution. Meanwhile, the prevalence of obesity (BMI ⩾ 27 kg/m 2 ) in the current study was 3.2%. The relatively small size of the obese group resulted in lack of power and wide CI for estimated ORs of rapid eGFR loss and RFD. Second, annual eGFR decline, rapid eGFR loss and RFD were calculated from only two time point data: one at baseline and the other at revisit. More time point data would have enhanced the accuracy of rate estimation of eGFR loss and RFD classification. Third, we did not have urinary albumin data at baseline, and therefore we were not able to perform analysis on albuminuria. Fourth, owing to a low response rate (46%), it was possible that those individuals with the most severe risk factor burden would have died or developed significant disability in the interim. However, the nonresponders did not differ substantially with respect to baseline characteristics compared with the responders. Last, there are different definitions of overweight or obesity for the Chinese population. 16 Our study subjects are from a southern rural Chinese population, who are leaner than those from northern or urban Chinese areas. 26 Furthermore, the BMI level in our study (mean (s.d.), men: 21.3 (2.4); women: 22.1(2.7)) was similar or even lower than that in a Hong Kong sample in 2000 (men: 23.0 (3.8); women: 22.4 (3.6)). 27 In consideration of the low BMI levels and to assure decent sample size in different BMI categories, we set BMI cutoffs at 23.0 (overweight) and 27.0 (obese). Nevertheless, we have re-analyzed data with BMI cutoff levels set at 18.5, 23.0 and 27.5, and observed similar results (data not shown). In addition, we have explored the possible nonlinear relationship between BMI and renal dysfunction ( Figure 2 ). However, further studies to confirm our results are still warranted.
In summary, our results suggested a nonlinear S-shaped association between BMI and annual eGFR decline among Chinese adults with normal renal function. Further studies are needed to confirm our results and to investigate the mechanisms underlying the relationship of obesity with RFD.
